AstraZeneca Says Andexxa Will Not Convert To Full Approval, Quietly Reveals Complete Response
Whether the FDA will seek withdrawal of the anticoagulant-reversal agent or request additional confirmatory data is unclear.
Whether the FDA will seek withdrawal of the anticoagulant-reversal agent or request additional confirmatory data is unclear.